<DOC>
	<DOCNO>NCT01980329</DOCNO>
	<brief_summary>The purpose study evaluate influence genetic polymorphism cytochrome P450 3A5 pharmacokinetics maraviroc oxidative metabolite</brief_summary>
	<brief_title>Polymorphic Effects Cytochrome P450 3A5 Pharmacokinetics Maraviroc Its Metabolites</brief_title>
	<detailed_description>This study aim evaluate effect CYP3A5 genotype pharmacokinetics maraviroc oxidative metabolite . A single oral dose 300 mg maraviroc give 24 eligible healthy individual screen determine specific CYP3A5 genotype - 8 homozygous wild type ( 2 CYP3A5*1 allele ) , 8 heterozygous ( 1 CYP3A5*1 allele 1 mutant allele ) , 8 without wild type genotype ( 2 mutant allele ) . Blood sample draw urine sample collect immediately 32-hr period follow dose . The concentration maraviroc oxidative metabolite blood urine sample measure pharmacokinetics maraviroc metabolite compare among three group different CYP3A5 polymorphic status .</detailed_description>
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Healthy acute medical illness Willing provide write informed consent Age 1865 year Negative serum pregnancy test ( female ) screen negative urine pregnancy test ( female ) day dose HIV seronegative screening , determine license ELISA At screening , evidence hepatic renal impairment ( LFT 's &lt; 1.5 Upper Limit Normal ( ULN ) , creatinine clearance &gt; 60 ml/min , total bilirubin ULN , AST ALT 1.5 ULN ) 8 subject homozygous CYP3A5 allele *1 ( wild type ) 8 subject 1 CYP3A5*1 allele 1 mutant allele 8 subject CYP3A5 allele *1 Concomitant medication ( prescription overthecounter ) herbal supplement know risk pharmacokinetic pharmacodynamic drug interaction , include inhibit CYP3A4 list P450 Drug Interaction Table ( http : //medicine.iupui.edu/clinpharm/ddis/table.aspx ) History postural hypotension cardiovascular disease Active medical psychological condition , opinion investigator , might put volunteer undue risk interfere participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>CYP3A5</keyword>
	<keyword>maraviroc</keyword>
	<keyword>polymorphism</keyword>
</DOC>